Frequency of multiple Epstein-Barr virus infections in T-cell- immunocompromised individuals

Journal of Virology

Volumn 70, Issue 8, 1996, Pages 4884-4894

  Yao, Q Y ^a   Tierney, R J ^a   Croom Carter, D ^a   Dukers, D ^a   Cooper, G M ^b   Ellis, C J ^b   Rowe, M ^a   Rickinson, A B ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MEMORY CELL; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS ISOLATION;

EID: 8944258118     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.8.4884-4894.1996     Document Type: Article

References (59)

1. Abdel-Hamid, M., J. J. Chen, N. Constantine, M. Massoud, and N. Raab-Traub. 1992. EBV strain variation: geographical distribution and relation to disease state. Virology 190:168-175.
2. Adldinger, H. K., H. Delius, U. K. Freese, J. Clarke, and G. W. Bornkamm. 1985. A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes. Virology 141:221-234.
3. Aitken, C., S. K. Sengupta, C. Aedes, D. J. Moss, and T. B. Sculley. 1994. Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus. J. Gen. Virol. 75:95-100.
4. Alfieri, C., and J. H. Joncas. 1987. Biomolecular analysis of a defective nontransforming Epstein-Barr virus (EBV) from a patient with chronic active EBV infection. J. Virol. 61:3306-3309.
5. Anagnostopoulos, I., M. Hummel, C. Kreschel, and H. Stein. 1995. Morphology, immunophenotype and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood 85:744-750.
6. Apolloni, A., and T. B. Sculley. 1994. Detection of A-type and B-type Epstein-Barr virus in throat washings and lymphocytes. Virology 202:978-981.
7. Baer, R., A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell, T. G. Gibson, G. Hatfull, G. S. Hudson, S. C. Satchwell, C. Seguin, P. S. Tuffnel, and B. G. Barrell. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature (London) 310:207-211.
8. Ball, M. J., and D. Griffiths. 1985. Effect on chemical analyses of beta-propiolactone treatment of whole blood and plasma. Lancet i:1160-1161.
9. Boyle, M. J., W. A. Sewell, T. B. Sculley, A. Apolloni, J. J. Turner, C. E. Swanson, R. Penny, and D. A. Cooper. 1991. Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphomas. Blood 78:3004-3011.
10. Buisson, M., P. Morand, O. Genoulaz, M.-J. Bourgeat, M. Micoud, and J.-M. Seigneurin. 1914. Changes in the dominant Epstein-Barr virus type during human immunodeficiency virus infection. J. Gen. Virol. 75:431-437.
11. Burrows, S. R., T. B. Sculley, I. S. Misko, C. Schmidt, and D. J. Moss. 1990. An Epstein-Barr virus-specific cytotoxic T cell epitope in EBNA3. J. Exp. Med. 171:345-350.
12. Dambaugh, T., K. Hennessy, L. Chamnankit, and E. Kieff. 1984. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc. Natl. Acad. Sci. USA 81:7632-7636.
13. de Campos-Lima, P.-O., V. Levitsky, J. Brooks, S. P. Lee, L. F. Hu, A. B. Rickinson, and M. G. Masucci. 1994. T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from high A11-positive populations by selective mutation of anchor residues. J. Exp. Med. 179:1297-1305.
14. Falk, K., J. W. Gratama, M. Rowe, J. Z. Zou, F. Khanim, L. S. Young, M. A. P. Oosterveer, and I. Ernberg. 1995. The role of repetitive DNA sequences in the size variation of Epstein-Barr virus (EBV) nuclear antigens, and the identification of different EBV isolates using RFLP and PCR analysis. J. Gen. Virol. 76:779-790.
15. Frank, D., E. Cesarman, Y. F. Liu, R. E. Michler, and D. M. Knowles. 1995 Post-transplantation lymphoproliferative disorders frequently contain type A but not type B Epstein-Barr virus. Blood 85:1396-1403.
16. Gavioli, R., M. G. Kurilla, P. O. de Campos-Lima, L. E. Wallace, R. Dolcetti, R. J. Murray, A. B. Rickinson, and M. G. Masucci. 1993. Multiple HLA-A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. J. Virol. 67:1572-1578.
17. Grasser, F. A., P. G. Murray, E. Kremmer, K. Klein, K. Remberger, W. Feiden, G. Reynolds, G. Niedobitek, L. S. Young, and N. Muller-Lantzsch. 1994. Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1: immunohistochemical detection of EBNA1 in the malignant cells of Hodgkin's disease. Blood 84:3792-3799.
18. Gralama, J. W., E. T. Lennette, B. Lonnqvist, M. A. P. Oosterveer, G. Klein, O. Ringden, and I. Ernberg. 1992. Detection of multiple Epstein-Barr viral strains in allogeneic bone marrow transplant recipients. J. Med. Virol. 37: 39-47.
19. Gratama, J. W., M. A. P. Oosterveer, G. Klein, and I. Ernberg. 1990. EBNA size polymorphism can be used to trace Epstein-Barr virus spread within families. J. Virol. 64:4703-4708.
20. Gratama, J. W., M. A. P. Oosterveer, W. Weimar, K. Sintnicolaas, W. Sizoo, R. L. H. Bolhuis, and I. Ernberg. 1994. Detection of multiple 'Ebnotypes' in individual Epstein-Barr virus carriers following lymphocyte transformation by virus derived from peripheral blood and oropharynx. J. Gen. Virol. 75: 85-94.
21. Gratama, J. W., M. A. P. Oosterveer, F. E. Zwaan, J. Lepoutre, G. Klein, and I. Ernberg. 1988. Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency. Proc. Natl. Acad. Sci. USA 85:8693-8696.
22. Greenspan, J. S., D. Greenspan, E. T. Lennette, D. I. Ahrams, M. A. Conant, V. Petersen, and U. K. Freese. 1985. Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associatcd lesion. N. Engl. J. Med. 313:1564-1571.
23. Khanim, F., Q. Y. Yao, G. Niedobitek, S. Sihota, A. B. Rickinson, and L. S. Young. Analysis of Epstein-Barr virus gene polymorphisms in geographically distinct virus isolates of normal donor and lumour origin. Submitted for publication.
24. Kunimolo, M., S. Tamura, T. Tabata, and O. Yoshie. 1992. One-step typing of Epstein-Barr virus by polymeryse chain reaction: predominance of type 1 virus in Japan. J. Gen. Virol. 73:455-461.
25. Kyaw, M. T., L. Hurren, L. Evans, D. J. Moss, D. A. Cooper, E. Benson, E. Esmore, and T. B. Sculley. 1992. Expression of B-type Epstein-Barr virus in HIV-infected patients and cardiac transplant recipients. AIDS Res. Hum. Retroviruses 8:1869-1874.
26. Lee, S. P., W. A. Thomas, R. J. Murray, F. Khanim, S. Kaur, L. S. Young, M. Rowe, M. Kurilla, and A. B. Rickinson. 1993. HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2. J. Virol. 67:7428-7435.
27. Lung, M. L., W. P. Lam, J. Sham, D. Chong, Y. S. Zong, H. Y. Guo, and M. H. Ng. 1991. Detection and prevalence of the "f" variant of Epstein-Barr virus in Southern China. Virology 185:67-71.
28. Luxton, J. C., A. Williams, I. Weller, and D. H. Crawford. 1993. Epstein-Barr virus infection of HIV-seropositive individuals is transiently suppressed by high dose acyclovir treatment. AIDS 7:1337-1343.
29. Maunders, M. J., L. Petti, and M. Rowe. 1994. Precipitation of the Epstein-Barr virus protein EBNA2 by an EBNA 3C-specific monoclonal antibody. J. Gen. Virol. 75:769-778.
30. Miller, W. E., R. H. Edwards, D. M. Walling, and N. Raab-Traub. 1994. Sequence variation in the Epstein-Barr virus latent membrane protein 1. J. Gen. Virol. 75:2729-2740.
31. Nilsson, K., G. Klein, W. Henle, and G. Henle. 1971. The establishment of lymphoblastoid cell lines from adult and from foetal human lymphoid tissue and its dependence on EBV. Int. J. Cancer 8:443-450.
32. Rahman, M. A., L. A. Kingsley, M. K. Breinig, M. Ho, J. A. A. Armstrong, R. W. Atchison, D. W. Lyter, and C. R. Rinaldo. 1989. Enhanced antibody responses to Epstein-Barr virus in HIV-infected homosexual men. J. Infect. Dis. 159:472-479.
33. Rickinson, A. B., D. J. Moss, L. E. Wallace, M. Rowe, I. S. Misko, M. A. Epstein, and J. H. Pope. 1981. Long-term T-cell-mediated immunity to Epstein-Barr virus. Cancer Res. 41:4216-4221.
34. Rickinson, A. B., L. S. Young, and M. Rowe. 1987. Influence of the Epstein-Barr virus nuclear antigen EBNA2 on the growth phenotype of virus-transformed B cells. J. Virol. 61:1310-1317.
35. Rowe, M., D. T. Rowe, C. D. Gregory, L. S. Young, P. J. Farrell, H. Rupani, and A. B. Rickinson. 1987. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J. 6:2743-2751.
36. Rowe, M., L. S. Young, K. Cadwallader, L Petti, E. Kieff, and A. B. Rickinson. 1989. Distinction between Epstein-Barr virus type A (EBNA2A) and type B (EBNA2B) isolates extends to the EBNA3 family of nuclear proteins. J. Virol. 63:1031-1039.
37. Sample, J., E. F. Kieff, and E. D. Kieff. 1994. Epstein-Barr virus types 1 and 2 have nearly identical LMP1 transforming genes. J. Gen. Virol. 75:2741-2746.
38. Sample, J., L. Young, B. Martin, T. Chatman, E. Kieff, A. Rickinson, and E. Kieff. 1990. Epstein-Barr virus types 1 (EBV-1) and 2 (EBV-2) differ in their EBNA-3A, EBNA-3B. and EBNA-3C genes. J. Virol. 64:4084-4092.
39. Sculley, T. B., A. Apolloni, L. Hurren, D. J. Moss, and D. A. Cooper. 1990. Co-infection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects. J. Infect. Dis. 162:643-648.
40. Sculley, T. B., A. Apolloni, D. J. Moss, N. Muller-Lantsch, I. S. Misko, and D. A. Cooper. 1989. Expression of Epstein-Barr virus nuclear antigens 3, 4 and 6 are altered in cell lines containing B type virus. Virology 171:401-408.
41. Sculley, T. B., S. M. Cross, P. Borrow, and D. A. Cooper. 1988. Prevalence of antibodies to Epstein-Barr virus nuclear antigen 2B in persons infected with the human immunodeficiency virus. J. Infect. Dis. 158:186-192.
42. Sixbey, J. W., J. G. Nedrud, N. Raab-Traub, R. A. Hanes, and J. S. Pagano. 1984. Epstein-Barr virus replication in oropharyngeal epithelial cells. N. Engl. J. Med. 310:1225-1230.
43. Sixbey, J. W., P. Shirley, P. J. Chesney, D. M. Buntin, and L. Resnick. 1989. Detection of a second widespread strain of Epstein-Barr virus. Lancet ii:761-765.
44. Sixbey, J. W., P. Shirley, M. Sloas, N. Raab-Traub, and V. Israele. 1991. A transformation-incompetent, nuclear antigen 2-deleted Epstein-Barr virus associated with replicative infection. J. Infect. Dis. 163:1008-1015.
45. Thorley-Lawson, D. A., and K. Geilinger. 1980. Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralise infectivity. Proc. Natl. Acad. Sci. USA 77:5307-5311.
46. Tierney, R. J., N. Steven, L. S. Young, and A. B. Rickinson. 1994. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J. Virol. 68:7374-7385.
47. Walling, D. M., N. M. Clark, D. M. Markovitz, T. S. Frank, D. K. Brawn, E. Eisenberg, D. J. Krutchkoff, D. H. Felix, and N. Raab-Traub. 1995. Epstein-Barr virus co-infection and recombination in non-human-immunodeficiency virus-associated oral hairy leukoplakia. J. Infect. Dis. 171:1122-1130.
48. Walling, D. M., S. N. Edmistan, J. W. Sixbey, M. Abdel-Hamid, L. Resnick, and N. Raab-Traub. 1992. Co-infection of multiple strains of the Epstein-Barr virus in human immunodeficiency virus-associated hairy leukoplakia. Proc. Natl. Acad. Sci. USA 89:6560-6564.
49. Walling, D. M., A. G. Perkins, J. Webster-Cyriaque, L. Resnick, and N. Raab-Traub. 1994. The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression. J. Virol. 68:7918-7926.
50. Walling, D. M., and N. Raab-Traub. 1994. Epstein-Barr virus intrastrain recombination in oral hairy leukoplakia. J. Virol. 68:7909-7917.
51. Yao, Q. Y., et al. Unpublished observations.
52. Yao, Q. Y., P. Ogan, M. Rowe, M. Wood, and A. B. Rickinson. 1989. Epstein-Barr virus-infected B cells persist in the circulation of acyclovir-treatcd virus carriers. Int. J. Cancer 43:67-71.
53. Yao, Q. Y., A. B. Rickinson, and M. A. Epstein. 1985. A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals. Int. J. Cancer 35:35-42.
54. Yao, Q. Y., M. Rowe, B. Martin, L. S. Young, and A. B. Rickinson. 1991. The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers. J. Gen. Virol. 72:1579-1590.
55. Yao, Q. Y., M. Rowe, A. J. Morgan, C. K. Sam, U. Prasad, H. Dong, Y. Zeng, and A. B. Rickinson. 1991. Salivary and serum IgA antibodies to the Epstein-Barr virus glycoprotein gp340: incidence and potential for virus neutralization. Int. J. Cancer 48:45-50.
56. Yao, Q. Y., R. J. Tierney, D. Croom-Carter, G. M. Cooper, C. J. Ellis, M. Rowe, and A. B. Rickinson. 1996. Isolation of intertypic recombinants of Epstein-Barr virus from T-cell-immunocompromised individuals. J. Virol. 70:4895-4903.
57. Young, L., C. Alfieri, K. Hennessy, H. Evans, C. O'Hara, K. C. Anderson, J. Ritz, R. S. Shapiro, A. Rickinson, E. Kieff, and J. I. Cohen. 1989. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N. Engl. J. Med. 321:1080-1085.
58. Young, L. S., Q. Y. Yao, C. M. Rooney, T. B. Sculley, D. J. Moss, H. Rupani, G. Laux, G. W. Bornkamm, and A. B. Rickinson. 1987. New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas. J. Gen. Virol. 68:2853-2862.
59. Zimber, U., H. K. Adldinger, G. M. Lenoir, M. Vuillaume, M. V. Knebel-Doeberitz, G. Laux, C. Desgranges, P. Wittman, U. K. Freese, U. Schneider, and G. W. Bornkamm. 1986. Geographic prevalence of two Epstein-Barr virus types. Virology 154:56-66.